MINDRAMP PODCAST - LIVE LONG, LIVE WELL

CONTROVERSY ABOUT FDA APPROVAL OF NEW ALZHEIMER'S DRUG

July 09, 2021 Michael C Patterson Season 2 Episode 5
MINDRAMP PODCAST - LIVE LONG, LIVE WELL
CONTROVERSY ABOUT FDA APPROVAL OF NEW ALZHEIMER'S DRUG
Show Notes

The FDA recently approved the first new drug for Alzheimer's in the last 18 years. .   Why are we not celebrating? Because there  are a slew of concerns about the approval decision. Ten out of eleven members of an independent review board voted against approval. The eleventh couldn't decide.  At least three of these reviewer have resigned in protest. In this podcast I review four of the main concerns about the FDA approval of Aduhelm.